Skystar Bio Pharmaceutical Company (NASDAQ:SKBI) represents an interesting potential investment opportunity. The company provides niche products for China's animal husbandry industry. Skystar aims to provide products that improve profitability and efficiency for small and medium-sized animal farmers. China has become the second largest country after the U.S. for the consumption of animal health products. Skystar stands to benefit since the veterinary medicine industry in China is growing by 15% annually. By the end of 2013, Skystar had over 4,000 customers in 29 provinces in China.
The company operates four product lines. The veterinary medicine line is the largest product line as it comprised 60% of 2013 revenue. Skystar's veterinary medicine line has over 145 products for poultry and...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|